TY - JOUR
T1 - Inflammatory bowel disease
T2 - A potential result from the collusion between gut microbiota and mucosal immune system
AU - Yue, Bei
AU - Luo, Xiaoping
AU - Yu, Zhilun
AU - Mani, Sridhar
AU - Wang, Zhengtao
AU - Dou, Wei
N1 - Funding Information:
Funding: This work was funded by grants from the National Natural Science Foundation of China (81920108033, 81530096) and Natural Science Foundation of Shanghai (17ZR1427800).
Publisher Copyright:
© 2019 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2019/10
Y1 - 2019/10
N2 - Host health depends on the intestinal homeostasis between the innate/adaptive immune system and the microbiome. Numerous studies suggest that gut microbiota are constantly monitored by the host mucosal immune system, and any slight disturbance in the microbial communities may contribute to intestinal immune disruption and increased susceptibility to inflammatory bowel disease (IBD), a chronic relapsing inflammatory condition of the gastrointestinal tract. Therefore, maintaining intestinal immune homeostasis between microbiota composition and the mucosal immune system is an effective approach to prevent and control IBD. The overall theme of this review is to summarize the research concerning the pathogenesis of IBD, with particular focus on the factors of gut microbiota-mucosal immune interactions in IBD. This is a comprehensive and in-depth report of the crosstalk between gut microbiota and the mucosal immune system in IBD pathogenesis, which may provide insight into the further evaluation of the therapeutic strategies for IBD.
AB - Host health depends on the intestinal homeostasis between the innate/adaptive immune system and the microbiome. Numerous studies suggest that gut microbiota are constantly monitored by the host mucosal immune system, and any slight disturbance in the microbial communities may contribute to intestinal immune disruption and increased susceptibility to inflammatory bowel disease (IBD), a chronic relapsing inflammatory condition of the gastrointestinal tract. Therefore, maintaining intestinal immune homeostasis between microbiota composition and the mucosal immune system is an effective approach to prevent and control IBD. The overall theme of this review is to summarize the research concerning the pathogenesis of IBD, with particular focus on the factors of gut microbiota-mucosal immune interactions in IBD. This is a comprehensive and in-depth report of the crosstalk between gut microbiota and the mucosal immune system in IBD pathogenesis, which may provide insight into the further evaluation of the therapeutic strategies for IBD.
KW - Gut microbiota
KW - Inflammatory bowel disease
KW - Mucosal immune system
UR - http://www.scopus.com/inward/record.url?scp=85074332125&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074332125&partnerID=8YFLogxK
U2 - 10.3390/microorganisms7100440
DO - 10.3390/microorganisms7100440
M3 - Review article
AN - SCOPUS:85074332125
SN - 2076-2607
VL - 7
JO - Microorganisms
JF - Microorganisms
IS - 10
M1 - 440
ER -